Patch grafts of dehydrated cadaveric dura mater for tube-shunt glaucoma surgery.

Human donor sclera is commonly used in glaucoma surgery with a tube-shunt (eg, Molteno, Baerveldt, Shocket, Krupin-Denver) to cover the external portion of the silicone tube and prevent its erosion through the overlying conjunctiva. Common problems with this technique include immune-mediated melting of the graft and the potential for infectious disease transmission by the grafted material. A case is presented of a patient in whom a low-grade iridocyclitis was associated with the gradual melting of a scleral patch graft; the scleral patch was then replaced with commercially available, dehydrated human dura mater. The practical and theoretical advantages of cadaveric human dura mater in tube-shunt glaucoma surgery are discussed.

[1]  A. Mermoud,et al.  Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. , 1993, Ophthalmology.

[2]  R. Enzenauer,et al.  Treatment of scleromalacia perforans with dura mater grafting. , 1992, Ophthalmic surgery.

[3]  E. Cohen,et al.  Glaucoma associated with epithelial downgrowth controlled with Molteno tube shunts. , 1992, Ophthalmic surgery.

[4]  W. Steinmann,et al.  Aqueous shunts. Molteno versus Schocket. , 1992, Ophthalmology.

[5]  D. Minckler,et al.  Clinical experience with the single-plate Molteno implant in complicated glaucomas. Update of a pilot study. , 1992, Ophthalmology.

[6]  R. Weinreb,et al.  Preservation of Scleral Grafts to Avoid HIV Infection. , 1992, Journal of glaucoma.

[7]  D. Lotufo.  Postoperative complications and visual loss following Molteno implantation. , 1991, Ophthalmic surgery.

[8]  D. Minckler,et al.  Combined Molteno implantation and pars plana vitrectomy for neovascular glaucomas. , 1991, Ophthalmology.

[9]  D. Minckler,et al.  Molteno implantation for glaucoma in young patients. , 1991, Ophthalmology.

[10]  S. Sattar,et al.  Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. , 1991, Reviews of infectious diseases.

[11]  M. Blumenthal,et al.  Postoperative complications after Molteno implant surgery. , 1991, American journal of ophthalmology.

[12]  A. Tuulonen,et al.  Molteno implant surgery in uncontrolled glaucoma , 1990, Acta ophthalmologica.

[13]  P. McDonnell,et al.  Molteno implantation for secondary glaucomas associated with advanced epithelial ingrowth. , 1990, Ophthalmology.

[14]  H. Diringer,et al.  INFECTIVITY OF UNCONVENTIONAL VIRUSES IN DURA MATER , 1989, The Lancet.

[15]  S. Hammer,et al.  Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine. , 1989, Journal of acquired immune deficiency syndromes.

[16]  W. Barlow,et al.  Clinical experience with the single-plate Molteno implant in complicated glaucomas. , 1988, Ophthalmology.

[17]  R. E. Smith,et al.  Molteno implant for control of glaucoma in eyes after penetrating keratoplasty. , 1988, Ophthalmology.

[18]  J. Freedman.  Scleral patch grafts with Molteno setons. , 1987, Ophthalmic surgery.

[19]  D. Minckler,et al.  Experimental studies of aqueous filtration using the Molteno implant. , 1987, Transactions of the American Ophthalmological Society.

[20]  L. Resnick,et al.  Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. , 1986, JAMA.

[21]  P. Brown,et al.  Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus. , 1984, The New England journal of medicine.

[22]  J. Sever,et al.  Human-to-human transmission of rabies virus by corneal transplant. , 1979, The New England journal of medicine.

[23]  A. Devoe,et al.  Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. , 1974, The New England journal of medicine.